Skip to main content

Practice-Changing Data in NSCLC from ASCO 2021

Conference Correspondent
Mark A. Socinski, MD
Executive Medical Director
AdventHealth Cancer Institute
Orlando, FL
Dr Mark Socinski provides his insights into important new data on EGFR inhibitors and immunotherapy in the first-line setting for NSCLC.

Related Items